The Enterprise Value as of December 2025 (TTM) for Ascelia Pharma AB (publ) (ACE.ST) is 278.52M

According to Ascelia Pharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 278.52M. This represents a change of -10.32% compared to the average of 310.59M of the last 4 quarters.

Ascelia Pharma AB (publ) (ACE.ST) Historical Enterprise Value (quarterly & annually)

How has ACE.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Ascelia Pharma AB (publ) over the last ten years is 408.62M. The current 278.52M Enterprise Value has changed 6.72% with respect to the historical average. Over the past ten years (40 quarters), ACE.ST's Enterprise Value was at its highest in in the September 2020 quarter at 1.48B. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.

Ascelia Pharma AB (publ) (ACE.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ascelia Pharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascelia Pharma AB (publ) (ACE.ST) Average Enterprise Value

How has ACE.ST Enterprise Value performed in the past?

The current Enterprise Value of Ascelia Pharma AB (publ) (ACE.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ascelia Pharma AB (publ) (ACE.ST) Enterprise Value vs. Peers

How is ACE.ST’s Enterprise Value compared to its peers?

Ascelia Pharma AB (publ)’s Enterprise Value is greater than Mendus AB (publ) (215.77M), greater than Intervacc AB (publ) (133.77M), less than Magle Chemoswed Holding AB (publ) (667.02M), greater than Xintela AB (publ) (175.27M), greater than Moberg Pharma AB (publ) (189.53M), greater than Karolinska Development AB (publ) (57.49M), greater than Elicera Therapeutics AB (publ) (250.47M), greater than Isofol Medical AB (publ) (140.80M), less than Lipum AB (publ) (341.46M), greater than IRLAB Therapeutics AB (publ) (84.30M),

Build a custom stock screener for Ascelia Pharma AB (publ) (ACE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascelia Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascelia Pharma AB (publ) (ACE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascelia Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.